Researcher at Japanese Red Cross Kyoto Daini Hospital Releases New Data on Non-Small Cell Lung Cancer (First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung...).

Předmět:	NON-small-cell lung carcinoma PEMETREXED RESEARCH personnel IMMUNOTHERAPY LUNGS DATA release
Zdroj:	Immunotherapy Weekly; 10/31/2023, p1176-1176, 1p
Abstrakt:	Keywords: Cancer; Chemotherapy; Drugs and Therapies; Health and Medicine; Immunotherapy; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology; Therapy EN Cancer Chemotherapy Drugs and Therapies Health and Medicine Immunotherapy Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology Therapy 1176 1176 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Research findings on non-small cell lung cancer are discussed in a new report. Among the subgroup with 1-49% PD-L1 expression, the CIT group exhibited longer median PFS than the SEQ group (CIT: 9.3 months (95% CI: 6.7-14.8) vs. OS in the CIT group was significantly longer than that in the SEQ group in the 1-49% PD-L1 expression subgroup but not in the <1% PD-L1 expression subgroup. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu